Seladelpar Eases PBC-Related Itch for 30 Months

(MedPage Today) — WASHINGTON — Seladelpar (Livdelzi) provided sustained pruritus relief for up to 30 months in patients with primary biliary cholangitis (PBC), according to long-term data from the open-label ASSURE study.
Among participants…

Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118486

Author :

Publish date : 2025-11-12 22:10:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Seladelpar Eases PBC-Related Itch for 30 Months

Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial

At Hush-Hush MAHA Summit, Vance Praises RFK Jr. for Defying Convention

Related Posts

Risks of RFK Jr.’s New Vax Schedule; Dietary Guideline Errors; Measles Map

Berberine No Help for Metabolic Markers in Patients With Obesity and MASLD

CDC Studies Show Value of Wastewater Surveillance as Possible Funding Cut Looms

Darlington hospital violated trans complaint nurses’ dignity, tribunal rules

RFK Jr. Targets Cellphone Radiation; Ex-CEO of COVID Shot Maker Sued; Flu Vax Data

Stiffer Colon Could Signal Early-Onset CRC Risk

Risks of RFK Jr.’s New Vax Schedule; Dietary Guideline Errors; Measles Map

Berberine No Help for Metabolic Markers in Patients With Obesity and MASLD

CDC Studies Show Value of Wastewater Surveillance as Possible Funding Cut Looms

Darlington hospital violated trans complaint nurses’ dignity, tribunal rules

RFK Jr. Targets Cellphone Radiation; Ex-CEO of COVID Shot Maker Sued; Flu Vax Data

Stiffer Colon Could Signal Early-Onset CRC Risk

Cancelling plans may be more socially acceptable than you think

Inside the Gut Microbiome: Function, Disease and the Future

Categories

Archives